VSX2 antibody (C-Term)
Quick Overview for VSX2 antibody (C-Term) (ABIN955534)
Target
See all VSX2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 262-291, C-Term
-
Specificity
- This antibody detects VSX2 / CHX10 (C-term).
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human
-
Purification
- Protein A column followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 262-291 amino acids from the C-terminal region of human VSX2
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer.
-
-
- VSX2 (Visual System Homeobox 2 (VSX2))
-
Alternative Name
- VSX2 / CHX10
-
Background
- This gene encodes a homeobox protein originally described as a retina-specific transcription factor. Mutations in this gene are associated with microphthalmia, cataracts and iris abnormalities.Synonyms: Ceh-10 homeodomain-containing homolog, HOX10, Homeobox protein CHX10, Visual system homeobox 2
-
Gene ID
- 338917
-
NCBI Accession
- NP_878314
-
Pathways
- Dopaminergic Neurogenesis
Target
-